{
    "nctId": "NCT00874146",
    "briefTitle": "Level of HER2-neu Gene Amplification an Response to Trastuzumab",
    "officialTitle": "Retrospective Study of the Level of HER2-neu Gene Amplification as Predictive Factor of Response in Patients With HER2-positive Advanced Breast Cancer Treated With Trastuzumab Containing Regimens.",
    "overallStatus": "UNKNOWN",
    "conditions": "Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Association of tumor cytogenetic paremeters with TTP and OS.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* HER2-positive breast cancer Trastuzumab-containing regimen delivered for advanced disease Tumor sample available at Pathology Archive\n\nExclusion Criteria:\n\n* HER2-negative advanced breast cancer Pretreatment with trastuzumab",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}